Kaplan‐Meier analysis revealed that high expression of CD204 predicts a short overall survival (OS) both in the CGGA (Figure 1A and 1) and the TCGA dataset (Figure 1C) in whole‐grade glioma and low‐grade glioma (Figure S3A B and C). The gene discussed is MSR1; the disease is central nervous system cancer.